4.7 Article

Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment

Journal

FRONTIERS IN PHARMACOLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.911663

Keywords

gastric cancer; Trametes robiniophila Murr; 5-FU; MDSCs; CD8(+) T cells; NK cells

Ask authors/readers for more resources

The combination of TRM extract (TRMBE) and 5-FU can enhance the anticancer activity of 5-FU, prolong the survival time of mice bearing MFC xenograft tumors, and reduce the risk of liver metastasis in gastric cancer. This combination therapy also modulates immune cytokines, reshapes the tumor microenvironment, and improves the therapeutic effects of 5-FU.
Trametes robiniophila Murr (TRM) is a traditional Chinese medicine which has been used in clinics for enhancing immunity and improving the efficacy of chemotherapy. However, the mechanisms of action of TRM are unknown. In the previous study, we found that the Trametes robiniophila Murr n-butanol extract (TRMBE) comprises the major bioactive components of TRM. In the present study, we aimed to assess the combinational effects of TRMBE and 5-fluorouracil (5-FU) on the treatment of gastric cancer (GC) and explore its mechanism of action. It was found that TRMBE significantly potentiated the anticancer activity of 5-FU and prolonged the survival time of mice bearing Mouse Forestomach Carcinoma (MFC) xenograft tumors. We observed that the combination of TRMBE and 5-FU decreased the risk of liver metastasis in vivo. Furthermore, the combination of TRMBE and 5-FU reduced the levels of immune cytokines IL-6, IL-10, and TGF-beta and increased the level of IFN-gamma in peripheral blood. This combination therapy also significantly decreased the levels of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) and PD-1-positive CD8(+) T cells and increased the levels of NK cells in tumor microenvironment (TME). However, TRMBE treatment was unable to enhance the chemosensitivity of GC to 5-FU in vivo after the depletion of CD8(+) T and NK cells. Taken together, our results demonstrate that TRMBE can reshape the TME of GC by regulating PMN-MDSCs, CD8(+) T cells, and NK cells, therefore improving the therapeutic effects of 5-FU. This study suggests that the combination of TRMBE and 5-FU could enhance immunity and could be a promising approach for GC treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Applied

Structure elucidation of a novel cyclic tripeptide from the marine-derived fungus Aspergillus ochraceopetaliformis DSW-2

Yanyan Liao, Xuan Hong, Jing Yang, Jiang-Jiang Qin, Beibei Zhang, Jianhui Lin, Zongze Shao, Weiyi Wang

Summary: A novel cyclic tripeptide, sclerotiotide M (1), was isolated from the culture of marine derived fungus Aspergillus ochraceopetaliformis DSW-2, along with four known compounds. The structure of sclerotiotide M (1) was determined through various analytical methods, and it, along with the other compounds, exhibited weak cytotoxic activities against cancer cell lines HPAC and BXPC3.

NATURAL PRODUCT RESEARCH (2022)

Review Biochemistry & Molecular Biology

Recent Developments in Targeting Bromodomain and Extra Terminal Domain Proteins for Cancer Therapeutics

Maohua Cai, Jinyun Dong, Haobin Li, Jiang-Jiang Qin

Summary: Bromodomain and extra-terminal domain (BET) proteins are associated with various diseases, and the development of new BET inhibitors is urgently needed.

CURRENT MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Predicting hERG channel blockers with directed message passing neural networks

Mengyi Shan, Chen Jiang, Jing Chen, Lu-Ping Qin, Jiang-Jiang Qin, Gang Cheng

Summary: In this study, a classification model for identifying hERG blockers was developed using the D-MPNN model based on diverse datasets, and the D-MPNN + moe206 model showed significantly improved performance. Our results indicated that the D-MPNN + moe206 model is among the best classification models and has potential applications in the discovery of novel and effective hERG blockers.

RSC ADVANCES (2022)

Editorial Material Pharmacology & Pharmacy

Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy

Songtao Li, Zhenyuan Song, Ping Yao, Jiangjiang Qin

FRONTIERS IN PHARMACOLOGY (2022)

Article Biotechnology & Applied Microbiology

Characterization of a bioactive meroterpenoid isolated from the marine-derived fungus Talaromyces sp.

Xuan Hong, Xiaoqing Guan, Qiliang Lai, Dehua Yu, Zhongwei Chen, Xiaoteng Fu, Beibei Zhang, Changkun Chen, Zongze Shao, Jinmei Xia, Jiang-Jiang Qin, Weiyi Wang

Summary: A new meroterpenoid, taladrimanin A (1), was isolated from a marine-derived fungus, and its structure and activity were studied. Compound 1 showed inhibitory activity against gastric cancer cells and certain bacteria.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2022)

Editorial Material Biochemistry & Molecular Biology

Editorial: Biology and Pharmacological Effects of Extracellular Vesicles in Cancer

Jian-ye Zhang, Jiang-Jiang Qin, Dongmei Zhang, Dong-Hua Yang

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Editorial Material Cell Biology

Targeting mitophagy to promote apoptosis is a potential therapeutic strategy for cancer

Yancheng Tang, Liming Wang, Jiangjiang Qin, Yingying Lu, Han-Ming Shen, Hu-Biao Chen

Summary: Inhibition of PINK1-PRKN-mediated mitophagy enhances the anticancer efficacy of magnolol and could be a promising therapeutic strategy for overcoming cancer drug resistance and improving the therapeutic efficacy of anticancer agents.

AUTOPHAGY (2023)

Article Biochemistry & Molecular Biology

Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)

Jinyun Dong, Jing Yang, Wenkai Yu, Haobin Li, Maohua Cai, Jing-Li Xu, Han-Dong Xu, Yun-Fu Shi, Xiaoqing Guan, Xiang-Dong Cheng, Jiang-Jiang Qin

Summary: The study found that the quinolin-6-yl substituted derivative KL-6 effectively inhibited the growth and invasion of gastric cancer cells, and induced apoptosis. The compound also showed anticancer activity in a mouse model of gastric cancer without significant toxicity. Therefore, KL-6 may be a promising candidate for further research and development of gastric cancer treatment drugs.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Targeting KRAS mutant cancers: from druggable therapy to drug resistance

Chunxiao Zhu, Xiaoqing Guan, Xinuo Zhang, Xin Luan, Zhengbo Song, Xiangdong Cheng, Weidong Zhang, Jiang-Jiang Qin

Summary: KRAS is the most frequently mutated oncogene in various tumor types and has been considered undruggable due to the lack of classic drug binding sites. However, the development of KRAS inhibitors has made KRAS mutations druggable. Despite remarkable clinical responses, resistance to monotherapy of KRAS inhibitors has been observed. Significant progress has been made in understanding the mechanisms of drug resistance to KRAS-mutant inhibitors.

MOLECULAR CANCER (2022)

Article Pharmacology & Pharmacy

Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: In vitro and in vivo activity and mechanisms of action

Jing Yang, Lingling Wang, Xiaoqing Guan, Jiang-Jiang Qin

Summary: STAT3 is a critical player in cell signal transmission, making it a promising target for anticancer drug development. Many natural products have been shown to inhibit the STAT3 signaling pathway, demonstrating significant anticancer activities, but there is currently no FDA-approved STAT3 inhibitor.

PHARMACOLOGICAL RESEARCH (2022)

Article Microbiology

Indole Diketopiperazine Alkaloids Isolated From the Marine-Derived Fungus Aspergillus chevalieri MCCC M23426

Dongli Lv, Jinmei Xia, Xiaoqing Guan, Qiliang Lai, Beibei Zhang, Jianhui Lin, Zongze Shao, Sulan Luo, Dongting Zhangsun, Jiang-Jiang Qin, Weiyi Wang

Summary: Two new bioactive compounds were isolated from a deep-sea-derived fungus and their structures were determined. Compounds 1, 5-7 exhibited significant inhibition against Staphylococcus aureus, while compound 8 showed potent reduction in cell viability of gastric cancer cells.

FRONTIERS IN MICROBIOLOGY (2022)

Article Pharmacology & Pharmacy

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer

Haobin Li, Lingling Wang, Fei Cao, Dehua Yu, Jing Yang, Xuefei Yu, Jinyun Dong, Jiang-Jiang Qin, Xiaoqing Guan

Summary: The study reports the design and synthesis of a class of STAT3 degraders based on proteolysis-targeting chimeras (PROTACs). The SDL-1 compound achieved degradation of STAT3 protein in vitro and exhibited good anti-gastric cancer cell proliferation activity, as well as inhibiting invasion and metastasis.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation

Haobin Li, Maohua Cai, Fei Cao, Dehua Yu, Jing Yang, Wenkai Yu, Chu Chu, Xiaoqing Guan, Jiang-Jiang Qin, Jinyun Dong

Summary: A series of new STAT3 inhibitors were synthesized and the representative compound SIL-14 demonstrated strong anti-proliferation activity, inhibited colony formation and migration of gastric cancer cells, and induced cell apoptosis. It also inhibited the STAT3 signaling pathway, indicating its potential as an anticancer agent.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Review Pharmacology & Pharmacy

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies

Xiaofan Wu, Hongjian Yang, Xingfei Yu, Jiang-Jiang Qin

Summary: Breast cancer is a common malignancy in women, and HER2 overexpression is associated with poor prognosis. Pertuzumab and trastuzumab are the primary treatment options for early-stage HER2-positive breast cancer, and antibody-drug conjugates and tyrosine kinase inhibitors improve prognosis for metastatic breast cancer patients. However, resistance to targeted therapy is an issue that needs to be addressed.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism

Handong Xu, Can Hu, Yi Wang, Yunfu Shi, Li Yuan, Jingli Xu, Yanqiang Zhang, Jiahui Chen, Qin Wei, Jiangjiang Qin, Zhiyuan Xu, Xiangdong Cheng

Summary: Gastric cancer (GC) is a deadly malignancy that requires new therapeutic targets for effective treatment. Glutathione peroxidase-2 (GPx2) was found to be overexpressed in clinical GC samples and negatively correlated with prognosis. Knockdown of GPx2 inhibited GC progression and metastasis by suppressing the KYNU-kyn-AhR signaling pathway, which was activated by reactive oxygen species (ROS) accumulation.

ONCOGENE (2023)

No Data Available